Enfusion

Enfusion EPS

Delisted

The Earnings per Share (EPS) of Enfusion (ENFN) as of Nov 7, 2026 is 0.02 USD. In the previous year, Earnings per Share (EPS) was 0.05 USD — a change of -53.79% (lower).

EPS

0.02USD

YoY

-53.79%

Last updated:

Earnings per Share (EPS) of Enfusion is 2024 0.02 USD. Earnings per Share (EPS) of Enfusion was 2023 0.05 USD. It decreases by -53.79% lower compared to the previous year.

The Enfusion EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2020
0.06 USD
Jan 1, 2021
-3.39 USD
Jan 1, 2022
-0.10 USD
Jan 1, 2023
0.05 USD
Jan 1, 2024
0.02 USD
Jan 1, 2025 (e)
0.23 USD
Jan 1, 2026 (e)
0.35 USD
Jan 1, 2027 (e)
0.39 USD
The Enfusion EPS history
YEAREPSYoY
est0.39USD+12.14%
est0.35USD+52.70%
est0.23USD+946.84%
0.02USD-53.79%
0.05USD-147.27%
-0.10USD-97.06%
-3.39USD-5,453.97%
0.06USD-43.38%
0.11USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Earnings per Share (EPS) of Enfusion is 0.02 USD in 2024.

Earnings per Share (EPS) of Enfusion changed from 0.05 USD to 0.02 USD, representing a -53.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Enfusion since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Enfusion

All Key Metrics — Enfusion